These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thymic hormone in the treatment of cancer. Dardeene M; Bach JF Prog Clin Biol Res; 1989; 288():363-82. PubMed ID: 2654955 [No Abstract] [Full Text] [Related]
3. Thymus, thymus hormones and cancer. Van Den Tweel JG; Hensen EJ Neth J Med; 1976; 19(4-5):191-5. PubMed ID: 980186 [No Abstract] [Full Text] [Related]
4. Thymosin and the endocrine thymus. Schulof RS; Goldstein AL Adv Intern Med; 1977; 22():121-43. PubMed ID: 320839 [No Abstract] [Full Text] [Related]
5. The thymus in immunodeficiency diseases: new therapeutic approaches. Bach JF Birth Defects Orig Artic Ser; 1983; 19(3):245-53. PubMed ID: 6360235 [No Abstract] [Full Text] [Related]
6. Biochemical aspects of the function of the thymus gland. Di Sabato G Horiz Biochem Biophys; 1977; 3():297-325. PubMed ID: 69602 [No Abstract] [Full Text] [Related]
7. Biological and clinical properties of THF. Trainin N; Handzel ZT; Pecht M Thymus; 1985; 7(3):137-50. PubMed ID: 3875914 [No Abstract] [Full Text] [Related]
8. The Gordon Wilson lecture. The history of the development of thymosin: chemistry, biology and clinical applications. Goldstein AL Trans Am Clin Climatol Assoc; 1977; 88():79-94. PubMed ID: 331647 [No Abstract] [Full Text] [Related]
9. Proceedings: Infantile partial thymic deficiency: correction of some in vitro T functions by thymus humoral factor. Handzel ZT; Levin S; Hahn T; Altman Y; Ashkenazi A; Trainin N; Schechter B Isr J Med Sci; 1975 Dec; 11(12):1391. PubMed ID: 1082883 [No Abstract] [Full Text] [Related]
10. [Current discussion: the thymus gland and age]. Scheller EF Aktuelle Gerontol; 1980 Dec; 10(12):569-70. PubMed ID: 6116443 [No Abstract] [Full Text] [Related]
11. Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer. Goldstein AL Antibiot Chemother (1971); 1978; 24():47-59. PubMed ID: 350140 [No Abstract] [Full Text] [Related]
12. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies. Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238 [No Abstract] [Full Text] [Related]
13. [The endocrine thymus. Changes in its efficiency as a function of age]. Fabris N; Piantanelli L Minerva Med; 1979 Apr; 70(20):1507-11. PubMed ID: 313030 [No Abstract] [Full Text] [Related]
14. Thymosin treatment of children with primary immunodeficiency disease. Wara DW; Ammann AJ Transplant Proc; 1978 Mar; 10(1):203-9. PubMed ID: 305674 [No Abstract] [Full Text] [Related]
15. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies. Levinsky RJ; Davies EG; Goldstein G Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239 [No Abstract] [Full Text] [Related]
16. Differentiation of human bone marrow cells into T lymphocytes by in vitro incubation with thymic extracts. Touraine JL; Incefy GS; Touraine F; Rho YM; Good RA Clin Exp Immunol; 1974 May; 17(1):151-8. PubMed ID: 4549567 [TBL] [Abstract][Full Text] [Related]
17. Role of thymic hormones in neuroimmunomodulation. Their use in patients with phobic disorders. Covelli V; Munno I; Altamura M; Decandia P; Pellegrino NM; Marcuccio C; Caradonna L; Jirillo E Acta Neurol (Napoli); 1991 Oct; 13(5):457-66. PubMed ID: 1776534 [TBL] [Abstract][Full Text] [Related]
19. A case of Di George syndrome treated with thymopoietin pentapeptide (TP-5) demonstrating an adherent suppressor cell of lymphocyte function. Joffe MI; Sochett E; Pettifor JM; Rabson AR J Clin Lab Immunol; 1982 May; 8(1):69-73. PubMed ID: 6212686 [TBL] [Abstract][Full Text] [Related]